3i Group a world leader in private equity and venture capital, listed on the London Stock Exchange, invests €1.3 billion a year in Buyouts, Growth Capital and Venture Capital.
Farmigea, based in Pisa, Italy, is a niche leader in ophthalmic and gynaecologic pharmaceuticals. In 2004 the Company generated sales of € 20 million with 30% Ebitda.
3i Group Plc invested in a family buy-out of Farmigea in order to reconfigure the shareholding structure while assuring management continuity. Transaction value was approximately € 36 million.
Cross Border originated the transaction and acted as advisor for 3i Group due to its expertise in the healthcare industry and experience in family business. It is a classic case of Family Buy-out in which part of the shareholders re-invest in a leveraged transaction.